Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11771775 Pyrrolobenzodiazepine-antibody conjugates

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
July 21, 2020
Date of Patent
October 3, 2023
Patent Application Number
16934319
Patent Citations
‌
US Patent 7407951 Pyrrolobenzodiazepines
‌
US Patent 8940733 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
‌
US Patent 9321774 Pyrrolobenzodiazepines
‌
US Patent 9376440 Pyrrolobenzodiazepines as antiproliferative agents
‌
US Patent 9399641 Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates
‌
US Patent 9415117 Pyrrolobenzodiazepines and conjugates thereof
‌
US Patent 9624227 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
‌
US Patent 9889207 Pyrrolobenzodiazepines and conjugates thereof
‌
US Patent 9931414 Pyrrolobenzodiazepine-antibody conjugates
‌
US Patent 11318211 Dosage regimes for the administration of an anti-CD19 ADC
•••
Patent Inventor Names
Philip Wilson Howard
Patricius Hendrikus Cornelis Van Berkel
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11771775
Patent Primary Examiner
‌
Sheela J. Huff
CPC Code
‌
A61P 35/00
‌
A61K 47/6849
‌
A61K 47/6803
‌
C07K 16/2803

Find more entities like US Patent 11771775 Pyrrolobenzodiazepine-antibody conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.